Despite lowered adjustment on the externalizing dimensions, children of alcohol
abusers report that they enjoy being at school as much as other children.”
“Background: Electronic cigarettes (e-cigarettes) are growing in popularity, but little is known about the extent to which these selleck kinase inhibitor products are advertised to consumers.\n\nPurpose: To estimate expenditures for e-cigarette advertising in magazines, TV, the Internet, newspapers, and radio in the U.S. from 2011 to 2012.\n\nMethods: E-cigarette advertising data were obtained from leading media intelligence companies, Kantar Media and Nielsen. Estimated e-cigarette advertising expenditures were summarized across media channels for 2011 and 2012. Additional information on brands advertised and market-level buys (i.e., local versus national) also was examined.\n\nResults: Overall, e-cigarette advertising expenditures across media channels tripled from $6.4 million in 2011 to $18.3 million in 2012. Expenditures were highest in magazines and TV and lowest in newspapers and on the Internet. More than 80 unique brands were advertised, but blu eCigs dominated ad spending, comprising 76.7% of all e-cigarette advertising expenditures in 2012. National markets were increasingly targeted from
54.9% of Erastin cost ad buys in 2011 to 87.0% of ad buys in 2012.\n\nConclusions: E-cigarette advertising expenditures are increasing, with a greater focus on national markets and TV ads, which will likely increase consumer awareness and use of e-cigarettes in the future. Federal-level efforts are needed to mandate that e-cigarette companies report their advertising expenditures. Future studies should examine how e-cigarette advertising expenditures FK228 ic50 and message content influence consumer awareness of, interest in, and use of e-cigarettes. (C) 2014 American Journal of Preventive Medicine”
“Objective: To compare Rapid Rhino and Merocel packs for nasal packing after septoplasty, in terms of patient tolerance (both with the pack in place and during
removal) and post-operative complications.\n\nMaterial and methods: Thirty patients (aged 18-40 years) scheduled for septoplasty were included. Following surgery, one nasal cavity was packed with Rapid Rhino and the other one with Merocel. Patients were asked to record pain levels on a visual analogue score, on both sides, with the packs in situ and during their removal the next day. After pack removal, bleeding was compared on both sides.\n\nResults: The mean +/- standard deviation pain score for the Rapid Rhino pack in situ (4.17 +/- 1.78) was less than that for the Merocel pack (4.73 +/- 2.05), but not significantly so (p = 0.314). The mean pain score for Rapid Rhino pack removal (4.13 +/- 1.76) was significantly less that that for Merocel (6.90 +/- 1.67; p = 0.001). Bleeding after pack removal was significantly less for the Rapid Rhino sides compared with the Merocel sides (p < 0.05).